Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 16 | 2021 | 945 | 2.640 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 13 | 2020 | 237 | 2.630 |
Why?
|
| Calcium | 13 | 2024 | 1105 | 1.870 |
Why?
|
| Tacrolimus Binding Protein 1A | 5 | 2024 | 20 | 1.630 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2024 | 216 | 1.570 |
Why?
|
| Malignant Hyperthermia | 9 | 2022 | 19 | 1.560 |
Why?
|
| Sarcoplasmic Reticulum | 5 | 2024 | 196 | 1.190 |
Why?
|
| Calcium Channels, L-Type | 4 | 2015 | 53 | 0.950 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 120 | 0.820 |
Why?
|
| Muscular Diseases | 2 | 2021 | 103 | 0.800 |
Why?
|
| Mutation | 6 | 2021 | 5905 | 0.780 |
Why?
|
| Calcium Signaling | 5 | 2018 | 244 | 0.750 |
Why?
|
| Calcium-Binding Proteins | 4 | 2022 | 326 | 0.740 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2021 | 36 | 0.700 |
Why?
|
| Thermogenesis | 1 | 2020 | 46 | 0.680 |
Why?
|
| Heat Stress Disorders | 2 | 2022 | 10 | 0.580 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 585 | 0.580 |
Why?
|
| Mitochondria, Muscle | 2 | 2015 | 34 | 0.570 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 58 | 0.520 |
Why?
|
| Software | 1 | 2020 | 687 | 0.500 |
Why?
|
| Animals | 27 | 2024 | 34319 | 0.490 |
Why?
|
| CD36 Antigens | 1 | 2015 | 37 | 0.480 |
Why?
|
| Sirolimus | 2 | 2014 | 227 | 0.460 |
Why?
|
| Calmodulin | 3 | 2010 | 230 | 0.450 |
Why?
|
| Mice | 19 | 2024 | 17750 | 0.440 |
Why?
|
| Hot Temperature | 2 | 2012 | 136 | 0.440 |
Why?
|
| Calsequestrin | 4 | 2021 | 12 | 0.440 |
Why?
|
| Fatty Acids | 1 | 2015 | 344 | 0.410 |
Why?
|
| Ligands | 1 | 2014 | 538 | 0.410 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2012 | 23 | 0.380 |
Why?
|
| Death, Sudden | 2 | 2012 | 45 | 0.380 |
Why?
|
| Ribonucleotides | 1 | 2012 | 36 | 0.370 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 162 | 0.340 |
Why?
|
| Muscle Proteins | 3 | 2023 | 414 | 0.320 |
Why?
|
| Oxidative Stress | 3 | 2024 | 818 | 0.300 |
Why?
|
| Heat Stroke | 1 | 2008 | 4 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 4423 | 0.290 |
Why?
|
| Mice, Mutant Strains | 4 | 2017 | 385 | 0.250 |
Why?
|
| Muscle Contraction | 4 | 2022 | 188 | 0.250 |
Why?
|
| Peptides | 1 | 2009 | 812 | 0.250 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 495 | 0.240 |
Why?
|
| Myocardium | 2 | 2024 | 1022 | 0.220 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 67 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2015 | 171 | 0.210 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 199 | 0.210 |
Why?
|
| Muscle Weakness | 1 | 2023 | 85 | 0.200 |
Why?
|
| Models, Molecular | 3 | 2010 | 1085 | 0.190 |
Why?
|
| Halothane | 1 | 2021 | 11 | 0.180 |
Why?
|
| Mice, Inbred mdx | 1 | 2020 | 43 | 0.180 |
Why?
|
| Exons | 1 | 2023 | 802 | 0.180 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 26 | 0.180 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 33 | 0.180 |
Why?
|
| Lactates | 1 | 2020 | 94 | 0.170 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 2414 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 561 | 0.170 |
Why?
|
| Reactive Nitrogen Species | 2 | 2012 | 8 | 0.170 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 74 | 0.170 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 57 | 0.170 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2020 | 68 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1034 | 0.160 |
Why?
|
| Protein Binding | 3 | 2014 | 1756 | 0.160 |
Why?
|
| Heart | 1 | 2023 | 731 | 0.150 |
Why?
|
| Amino Acid Motifs | 2 | 2009 | 200 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3754 | 0.150 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 33 | 0.150 |
Why?
|
| Mitochondria | 2 | 2017 | 680 | 0.150 |
Why?
|
| Cell Nucleus | 1 | 2020 | 680 | 0.150 |
Why?
|
| Muscle Strength | 2 | 2008 | 74 | 0.140 |
Why?
|
| Male | 11 | 2021 | 61566 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 442 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2022 | 93 | 0.120 |
Why?
|
| Nitric Oxide Synthase | 1 | 2015 | 176 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 436 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 166 | 0.110 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2013 | 2 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 210 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 626 | 0.100 |
Why?
|
| Hypothermia | 1 | 2013 | 57 | 0.100 |
Why?
|
| Phenotype | 3 | 2020 | 4270 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1692 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 767 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2015 | 355 | 0.100 |
Why?
|
| Aortic Coarctation | 1 | 2013 | 110 | 0.090 |
Why?
|
| Isometric Contraction | 2 | 2008 | 22 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 228 | 0.090 |
Why?
|
| Crystallography, X-Ray | 2 | 2009 | 358 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 666 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2017 | 4595 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2022 | 1538 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 280 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 578 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2015 | 765 | 0.090 |
Why?
|
| Fever | 1 | 2013 | 300 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1818 | 0.080 |
Why?
|
| Humans | 13 | 2022 | 125362 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2013 | 257 | 0.080 |
Why?
|
| Caffeine | 3 | 2022 | 71 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 158 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 3176 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 93 | 0.080 |
Why?
|
| Raptors | 1 | 2008 | 5 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 2718 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 319 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2013 | 783 | 0.070 |
Why?
|
| Nitrosation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Rhabdomyolysis | 1 | 2008 | 37 | 0.070 |
Why?
|
| Mammals | 1 | 2009 | 257 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3900 | 0.070 |
Why?
|
| Oxidants | 1 | 2008 | 31 | 0.070 |
Why?
|
| Superoxides | 1 | 2008 | 129 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4409 | 0.070 |
Why?
|
| Long-Term Potentiation | 1 | 2008 | 161 | 0.070 |
Why?
|
| Fear | 1 | 2008 | 199 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 581 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 145 | 0.070 |
Why?
|
| Protein Conformation | 1 | 2009 | 837 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2008 | 331 | 0.070 |
Why?
|
| Cryoelectron Microscopy | 1 | 2008 | 214 | 0.070 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 66 | 0.070 |
Why?
|
| Young Adult | 1 | 2020 | 9061 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 198 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 825 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 12604 | 0.060 |
Why?
|
| Action Potentials | 1 | 2008 | 504 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 14151 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2009 | 879 | 0.060 |
Why?
|
| Gene Knock-In Techniques | 2 | 2018 | 122 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 645 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16369 | 0.050 |
Why?
|
| Adolescent | 1 | 2020 | 19430 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2022 | 30 | 0.050 |
Why?
|
| Neurons | 2 | 2008 | 1944 | 0.050 |
Why?
|
| Female | 5 | 2020 | 66821 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2007 | 1377 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 26763 | 0.040 |
Why?
|
| Child | 1 | 2020 | 24617 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 29543 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 380 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 224 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1017 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2008 | 325 | 0.030 |
Why?
|
| Anesthetics | 1 | 2018 | 79 | 0.030 |
Why?
|
| Metabolomics | 1 | 2021 | 422 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 973 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 739 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 587 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 30 | 0.030 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2015 | 31 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 705 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2008 | 1639 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1554 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2013 | 127 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 367 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 168 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 445 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 573 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 456 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 528 | 0.020 |
Why?
|
| Family | 1 | 2013 | 562 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1610 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 63 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 144 | 0.020 |
Why?
|
| Torque | 1 | 2008 | 11 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 300 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 53 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 273 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 3111 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 128 | 0.020 |
Why?
|
| Ryanodine | 1 | 2008 | 7 | 0.020 |
Why?
|
| Xanthine | 1 | 2008 | 7 | 0.020 |
Why?
|
| Exome | 1 | 2013 | 1034 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2008 | 42 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 238 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 307 | 0.020 |
Why?
|
| Point Mutation | 1 | 2009 | 351 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 127 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 296 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 130 | 0.020 |
Why?
|
| Organ Size | 1 | 2008 | 442 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1763 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 196 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 255 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 60 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 256 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 1505 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 351 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2008 | 314 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 491 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 404 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 989 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 491 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1465 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 2525 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6311 | 0.010 |
Why?
|
| Hypertension | 1 | 2007 | 1332 | 0.010 |
Why?
|